Effect of inducer and inhibitor probes on DNA adduction of benzo[a]pyrene and 2-acetylaminofluorene and their roles in defining bioactivation mechanism(s)

International Journal of Oncology

Volumn 8, Issue 4, 1996, Pages 681-685

  Arif, Jamal M ^a   Gupta, Ramesh C ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

2 acetylaminofluorene; 32P postlabeling; Benzo a pyrene; Cytochrome P450; DNA adducts

Indexed keywords

ALPHA NAPHTOFLAVONE; BENZO[A]PYRENE; BETA NAPHTOFLAVONE; CYCLOHEXANE OXIDE; CYTOCHROME P450; ENZYME INHIBITOR; N (2 FLUORENYL)ACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; LIVER MICROSOME; MALE; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029930017     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.8.4.681     Document Type: Article

References (18)

1. Guengerich FP and Shimada T: Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem Res Toxicol 4: 391-407, 1991.
2. Nedelcheva V and Gut I: P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotica 24: 1151-1175, 1994.
3. Ross J, Nelson G, Kligerman A, Erexson G, Bryant M, Early K, Gupta RC and Nesnow S: Formation and persistence of novel benzo[a]pyrene adducts in rat lung, liver, and peripheral blood lymphocyte DNA. Cancer Res 50: 5088-5094, 1990.
4. Halpert JR, Guengerich FP, Bend JR and Correia M: Selective inhibitors of cytochrome P450. Toxicol Appl Pharmacol 125: 163-175, 1994.
5. Chang TKH, Gonzalez FJ and Waxman DJ: Evaluation of tiacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochrome P450. Arch Biochem Biophys 311: 437-442, 1994.
6. Roy SK and Kulkarni AP: Dioxygenase and co-oxidase of rat hepatic cytosolic lipooxygenase. J Biochem Toxicol 9: 171-179, 1994.
7. 32P-postlabeling analysis of aromatic carcinogen: DNA adducts. Cancer Res 45: 5656-5662, 1985.
8. 32P-postlabeling analysis of bulky aromatic adducts. In: Postlabeling Methods of Detection of DNA Adducts. Phillips DH, Casteganro M and Bartsch H (eds). IARC, Lyon, pp 11-23, 1993.
9. Johannesen K, Depierre JW, Bergstrand A, Daliner G and Ernster L: Preparation and characterization of total rough and smooth microsomes from the lung of control and methylcholanthrene-treated rats. Biochim Biophys Acta 496: 115-135, 1977.
10. 32P-postlabeling assay. Carcinogenesis 13: 1053-1074, 1992.
11. Degawa M, Stern J, Marin MV, Guengerich FP, Fu PP, Ilett KF, Kaderlik KR and Kadlubar FF: Metabolic activation and, carcinogen-DNA adduct detection in human larynx. Cancer Res 54: 4915-4919, 1994.
12. Guenthner TM and Oesch F: The effect of modulation of microsomal epoxide hydrolase activity on microsome-catalyzed activation of benzo[a]pyrene and its covalent binding to DNA. Cancer Lett 11: 175-183, 1981.
13. Bu-Abbas A, Clifford MN, Walker R and Ioannides C: Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea. Carcinogenesis 15: 2575-2579, 1994.
14. Miller EC and Miller JA: Mechanism of chemical carcinogenesis. Cancer 47: 1055-1064, 1981.
15. Kadlubar F, Frederick C, Weiss C and Zenser T: Prostaglandin endoperoxide synthetase-mediated reaction of carcinogenic aromatic amines and their binding to DNA and protein. Biochem Biophys Res Commun 108: 253-258, 1982.
16. 32P-postlabeling. Carcinogenesis 17: 109-114, 1996.
17. Garner RC: Assessment of carcinogen exposure in man. Carcinogenesis 6: 1071-1078, 1985.
18. Smith WA and Gupta RC: Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. Carcinogenesis (In press).